Coya Therapeutics, Inc.
COYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001835022
No open-market purchases or sales by Coya Therapeutics, Inc. insiders were filed in the last 90 days; 54 institutions reported holding it in 13F filings for Q2 2026, worth $45.5M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Coya Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- 0 vs. Q4 2023
- Shares held
- 3.34M
- +1.81M (+118.7%) vs. Q4 2023
- Total value
- $33.1M
- +$22.1M (+199.8%) vs. Q4 2023
- New holders
- 4
- 9 more added
- Sold out
- 4
- 3 more reduced
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 54 | $45.5M |
| Q1 2026 | 57 | $32.0M |
| Q4 2025 | 58 | $46.0M |
| Q3 2025 | 36 | $27.1M |
| Q2 2025 | 33 | $25.8M |
| Q1 2025 | 26 | $30.2M |
| Q4 2024 | 26 | $25.5M |
| Q3 2024 | 19 | $21.4M |
| Q2 2024 | 19 | $19.8M |
| Q1 2024 | 19 | $33.1M |
| Q4 2023 | 21 | $20.6M |
| Q3 2023 | 15 | $5.45M |
| Q2 2023 | 14 | $5.50M |
| Q1 2023 | 7 | $4.37M |
| Q4 2022 | 4 | $5.16M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Coya Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DME Capital Management, LPSuperinvestorGreenlight Capital | 1,274,026 | $12.6M | 0.58% | +1,274,026 | New |
| Vanguard Group Inc | 847,490 | $8.41M | 0.00% | +750,338+772.3% | Added |
| AIGH Capital Management LLC | 649,427 | $6.44M | 3.11% | −382,550−37.1% | Reduced |
| Geode Capital Management, LLC | 125,996 | $1.25M | 0.00% | +33,531+36.3% | Added |
| Raymond James & Associates | 110,095 | $1.09M | 0.00% | +110,095 | New |
| CM Management, LLC | 100,000 | $992.0K | 0.83% | 00.0% | Unchanged |
| BlackRock Inc. | 53,997 | $535.6K | 0.00% | +32,222+148.0% | Added |
| State Street Corp | 46,200 | $458.3K | 0.00% | +46,200 | New |
| Prelude Capital Management, LLC | 35,770 | $354.8K | 0.02% | 00.0% | Unchanged |
| Royal Bank of Canada | 31,457 | $312.0K | 0.00% | +31,248+14,951.2% | Added |
| Northern Trust Corp | 25,467 | $252.6K | 0.00% | +10,594+71.2% | Added |
| Jane Street Group, LLC | 20,078 | $199.2K | 0.00% | +20,078 | New |
| Mirador Capital Partners LP | 15,481 | $153.6K | 0.03% | −646−4.0% | Reduced |
| Bank of America Corp | 1,625 | $16.1K | 0.00% | +1,615+16,150.0% | Added |
| UBS Group AG | 600 | $5.95K | 0.00% | −1,879−75.8% | Reduced |
| Morgan Stanley | 532 | $5.28K | 0.00% | +32+6.4% | Added |
| JPMorgan Chase & Co | 530 | $5.26K | 0.00% | +465+715.4% | Added |
| Tucker Asset Management LLC | 200 | $1.98K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $992 | 0.00% | +35+53.8% | Added |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −92,667−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,592−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,344−100.0% | Sold out |
| Tradition Wealth Management, LLC | 0 | $0 | 0.00% | −849−100.0% | Sold out |
| Greenlight Capital Inc | – | – | – | – | Not filed |
| Potomac Capital Management, Inc. | – | – | – | – | Not filed |